2009 - Gilde Healthcare

First dose-expansion patient successfully received SB-007  SB-007 addresses the root cause of Stargardt disease with the potential to treat patients across all ABCA4 mutations  SB-007 granted FDA Fast Track designation,...

Der Private Equity Fonds von Gilde Healthcare gibt den Erwerb der Mehrheitsanteile an Physio CKI von Kapital 1852 bekannt. Physio CKI ist eine wachstumsstarke Gruppe von Physiotherapiepraxen mit Hauptsitz in...

First dose-expansion patient successfully received SB-007  SB-007 addresses the root cause of Stargardt disease with the potential to treat patients across all ABCA4 mutations  SB-007 granted FDA Fast Track designation,...